Karl Hamouche, | |
551 N Hillside St Ste 320, Wichita, KS 67214-4926 | |
(316) 685-1367 | |
Not Available |
Full Name | Karl Hamouche |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 551 N Hillside St Ste 320, Wichita, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003309766 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 04-46948 (Kansas) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | 13237185-1205 (Utah) | Primary |
Entity Name | University Of Utah Adult Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.
Researchers at the University of Alabama at Birmingham and the University of Kansas Cancer Center have identified four hallmarks of cancer metastasis - when cancer has spread to different parts of the body from where it started. Metastasis is believed to be the cause of up to 90 percent of cancer deaths.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Karl Hamouche, 1010 N Kansas St, Wichita, KS 67214-3124 Ph: (316) 293-1818 | Karl Hamouche, 551 N Hillside St Ste 320, Wichita, KS 67214-4926 Ph: (316) 685-1367 |
News Archive
Caraco Pharmaceutical Laboratories, Ltd. announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities.
Researchers at the University of Alabama at Birmingham and the University of Kansas Cancer Center have identified four hallmarks of cancer metastasis - when cancer has spread to different parts of the body from where it started. Metastasis is believed to be the cause of up to 90 percent of cancer deaths.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.
› Verified 3 days ago
Dr. Larry C Graham Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-5050 Fax: 316-689-6192 | |
Tim Edward Stone, Radiology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2665 | |
Dr. Donald C S Tan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 817 N Emporia St, Via Christi Cancer Center, Wichita, KS 67214 Phone: 316-268-5927 | |
Elizabeth Perez-elmore, RN BSN Radiology Medicare: Not Enrolled in Medicare Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-685-2221 | |
Mike Lam, DO Radiology Medicare: Medicare Enrolled Practice Location: 1010 N Kansas St, Wichita, KS 67214 Phone: 316-293-2635 | |
Dr. Timothy C Benning, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3600 E Harry St, Wichita, KS 67218 Phone: 316-689-6173 |